Indinavir
-
Subject Areas on Research
- A clinical study of the combination of 100 mg ritonavir plus 800 mg indinavir as salvage therapy: influence of increased plasma drug levels in the rate of response.
- A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
- Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
- Antiretroviral medications: adverse effects on the kidney.
- Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor.
- Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
- Differences in durability of treatment with initial PI-based regimens.
- Drug resistance in patients experiencing early virological failure under a triple combination including indinavir.
- Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.
- Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
- Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
- Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.
- Taste and smell complaints in HIV-infected patients.
- The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis.